Latest Headlines

  1. BeOne Committing $1 Billion+ To U.S. Drug Manufacturing Growth 8/4/2026

    BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a $300 million expansion of its flagship clinical and commercial-stage manufacturing and research and development center at the Princeton West Innovation Campus in Hopewell, New Jersey, bringing total U.S. manufacturing investment to more than $1 billion. The expansion will increase BeOne's production capacity to manufacture its medicines and is expected to create approximately 120 new full-time jobs. The investment supports the continued advancement of BeOne's deep oncology pipeline of more than 35 clinical and commercial-stage assets.

  2. Why GSK Is Investing £400 Million In Cambridge 8/4/2026

    GSK plc (LSE/NYSE: GSK) today announced plans to establish a major new global R&D centre in Cambridge, UK, as part of the company’s plan to accelerate its R&D pipeline. The new 300,000 square foot site, on the Cambridge Biomedical Campus in the heart of the UK’s life sciences “Golden Triangle,” will be home to GSK’s R&D operations in the UK and more than 1,000 GSK scientists.

  3. Virtual Pharma Expo Launches Searchable Six-Year Equipment Demo Archive Ahead Of September Solid Dosage Event 7/30/2026

    Virtual Pharma Expo has launched a redesigned website that gives pharmaceutical manufacturing teams one place to watch every past equipment demonstration and register for upcoming live events.

  4. ROSS 250-Gallon Retention Mixers Designed For High-Pressure Processing 7/29/2026
  5. New Carrying Straps Simplify Handling Of Meissner's 16 L CryoVault® Container 7/27/2026
  6. Natoli Engineering Announces Acquisition Of Scheu & Kniss 7/23/2026

    Natoli Engineering Company, Inc., a global leader in tablet compression tooling, replacement parts, tablet presses, and technical services, today announced the acquisition of Scheu & Kniss, a company with more than a century of experience providing tablet press replacement parts, turret manufacturing, machine rebuilding, and technical support to the pharmaceutical, nutraceutical, confectionery, and industrial tablet manufacturing industries.

  7. Esco Lifesciences To Showcase Innovative Laboratory And Pharmaceutical Solutions At ISPE Singapore Conference & Exhibition 2026 7/17/2026

    Esco Lifesciences is pleased to announce its participation in the ISPE Singapore Conference & Exhibition 2026, taking place on 20–21 August 2026 at Suntec Singapore. Visitors are invited to meet the team at Booth 811 to explore the latest technologies supporting pharmaceutical manufacturing, aseptic processing, and laboratory operations.

  8. Amneal's Planned Sterile Facility Creates Opportunity For Aseptic Filling, Isolator, And Automation Suppliers 7/8/2026

    Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced it has been selected by the U.S. Food and Drug Administration (FDA) to participate in the FDA PreCheck Pilot Program for the company's planned sterile manufacturing facility in Brookhaven, New York.

  9. Lonza Expands HPAPI Capacity In Visp, Further Supporting Its Position In Payload-Linker Manufacturing 6/30/2026
  10. AustinPx Expands KinetiSol™ Technology Commercial Access Through Thermo Fisher Scientific Collaboration 6/30/2026

    AustinPx, a contract development and manufacturing organization (CDMO) specializing in bioavailability enhancement for orally delivered small molecule drugs, today announced its agreement with Thermo Fisher Scientific’s Patheon pharma services for the installation of AustinPx’s KinetiSol™ Technology equipment.